glp-1 camp New concept of the glucagon‐like peptide‐1 signaling pathway on pancreatic insulin secretion - Kaku - 2020 - Journal of Diabetes Investigation cAMP responses to titration of

This is a survival mechanism, not a character flaw

People lose an average of 25% of their body weight within a year after gastric sleeve, while you can lose up to 20% of your body weight within 72 weeks (a little over a year) of using tirzepatide (Zepbound)

"They can lead to substantial weight loss when used in conjunction with healthy lifestyle changes in people who are overweight or have obesity with or without type 2 diabetes," says Dr

Their weight loss solutions have completely transformed my life

Conte, C., Hall, K

4.3.1 Cardiovascular outcomes in GLP-1 RAs studies The ELIXA trial, which included 6068 patients, was the first to investigate the cardiovascular effects of GLP-1 RAs